Rituximab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Rituximab and local guidelines before prescribing.

Biologic (anti-CD20)

Mechanism

Anti-CD20 monoclonal antibody depleting B cells.

Uses

B-cell lymphoma, CLL, rheumatoid arthritis, ANCA vasculitis, ITP, membranous nephropathy, pemphigus.

Dosing

2 more dose entries from the chapters
  • Treatment - IV aciclovir 10 mg/kg every 8 hours (adjusted for kidney function) started immediately on suspicion - don't wait for CT, LP or PCR; usually 14–21 days for confirmed HSV encephalitis; hydrate well; treat seizures; immunotherapy (steroids, IVIG, plasma exchange, rituximab) for autoimmune encephalitis.
    ID: Sepsis, fever and serious bacterial infections
  • Treatment - glucocorticoids (rapid response - e.g. prednisolone 0.6 mg/kg tapering); rituximab for relapse; inebilizumab (anti-CD19) reduces flares; biliary stenting if obstructed.
    Clinical Immunology: Autoimmunity, autoantibodies and complement

Side effects

Infusion reactions, infections, hypogammaglobulinaemia, neutropenia, hepatitis B reactivation, PML.

Interactions

Live vaccines contraindicated; antihypertensives may need holding before infusion.

Contraindications and cautions

Active severe infection, hepatitis B, severe heart failure

Monitoring

Immunoglobulins, CD19 count, FBC, infection signs

Pregnancy and breastfeeding

Avoid in pregnancy; contraception for 12 months after

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive care; stop infusion

Special advice

Pre-medicate (steroid, antihistamine, paracetamol); screen hepatitis B before treatment; vaccinate before starting where possible.

More from the textbook: uses, cautions and other points
Where it is discussed in the book